PREVEP, INC.
Medtech
Intravenous topiramate formulation (PrevEp004) for treating status epilepticus and refractory seizures
- Grants
- $1.4M
- 4 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022202320242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Network Pharmacology for Epilepsy Prevention | $289,890 | |
| Federal grant | Department of Health and Human Services · Phase I · Network Pharmacology for Epilepsy Prevention | $410,113 | |
| Federal grant | Department of Health and Human Services · Phase I · Treatment of status epilepticus and refractory status epilepticus with intravenous topiramate. | $335,125 | |
| Federal grant | Department of Health and Human Services · Phase I · Treatment of status epilepticus and refractory status epilepticus with intravenous topiramate. | $367,387 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1479 | Exokinetics, Inc. | — | $100K |
| 1480 | Vista Robotics, Inc. | — | $275K |
| 1481 | Far Out Initiative Inc. | — | $55K |
| 1482 | PREVEP, INC. | — | — |
| 1483 | CuePath Innovation Inc. | — | $59K |
| 1484 | Pathway Labs, Inc. | — | $3.8M |
| 1485 | OBSIDIO, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Therapeutic Combinations, Liquid Pharmaceutical Compositions, Kits For Their Preparation, And Methods Of Their Useapplication
- Pharmaceutical Compositions Comprising Atorvastatin, Or A Salt Thereof, And A Liquid Carrierapplication
- Formulations Comprising Seletracetam And Methods Of Useapplication
- Pharmaceutical Compositions Comprising Atorvastatin, Or A Salt Thereof, And A Liquid Carrierapplication
- Formulations Comprising Seletracetam And Methods Of Useapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.